In this episode, Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center, shares progress in pediatric leukemia and sickle cell disease treatments, the impact of a 30-year partnership with Aflac, and breakthroughs in precision medicine, CAR T-cell therapy, and gene therapy that are reshaping outcomes for children and families.
Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center
Next Up in Becker's Healthcare Podcast Episodes
-
In this episode, Melinda Giese, Senior Vice President of Enterprise Client Solutions at CHG Healthcare, discusses building a flexible workforce…
-
In this episode, David Marcozzi, MD, MHS-CL, Senior Vice President and Chief Clinical Officer at University of Maryland Medical Center,…
-
In this episode, Himalee Sabnis, MD, MSc, Pediatric Hematologist and Oncologist at the Aflac Cancer and Blood Disorders Center of…
Comments are closed.